Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

A genetically humanized mouse model for hepatitis C virus infection.

Dorner M, Horwitz JA, Robbins JB, Barry WT, Feng Q, Mu K, Jones CT, Schoggins JW, Catanese MT, Burton DR, Law M, Rice CM, Ploss A.

Nature. 2011 Jun 8;474(7350):208-11. doi: 10.1038/nature10168.

2.

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.

Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L, Davis C, Mee CJ, Turek M, Gorke S, Royer C, Fischer B, Zahid MN, Lavillette D, Fresquet J, Cosset FL, Rothenberg SM, Pietschmann T, Patel AH, Pessaux P, Doffoël M, Raffelsberger W, Poch O, McKeating JA, Brino L, Baumert TF.

Nat Med. 2011 May;17(5):589-95. doi: 10.1038/nm.2341. Epub 2011 Apr 24.

3.

Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus.

Pawlotsky JM.

Hepatology. 2011 May;53(5):1742-51. doi: 10.1002/hep.24262. Review.

PMID:
21374691
4.

New direct-acting antivirals' combination for the treatment of chronic hepatitis C.

Asselah T, Marcellin P.

Liver Int. 2011 Jan;31 Suppl 1:68-77. doi: 10.1111/j.1478-3231.2010.02411.x. Review.

PMID:
21205141
5.

HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components.

Krementsov DN, Rassam P, Margeat E, Roy NH, Schneider-Schaulies J, Milhiet PE, Thali M.

Traffic. 2010 Nov;11(11):1401-14.

6.

Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.

Bitzegeio J, Bankwitz D, Hueging K, Haid S, Brohm C, Zeisel MB, Herrmann E, Iken M, Ott M, Baumert TF, Pietschmann T.

PLoS Pathog. 2010 Jul 1;6:e1000978. doi: 10.1371/journal.ppat.1000978.

7.

Mechanisms of viral entry: sneaking in the front door.

Thorley JA, McKeating JA, Rappoport JZ.

Protoplasma. 2010 Aug;244(1-4):15-24. doi: 10.1007/s00709-010-0152-6. Epub 2010 May 6. Review.

8.

Claudin association with CD81 defines hepatitis C virus entry.

Harris HJ, Davis C, Mullins JG, Hu K, Goodall M, Farquhar MJ, Mee CJ, McCaffrey K, Young S, Drummer H, Balfe P, McKeating JA.

J Biol Chem. 2010 Jul 2;285(27):21092-102. doi: 10.1074/jbc.M110.104836. Epub 2010 Apr 7.

9.

Glycoprotein D actively induces rapid internalization of two nectin-1 isoforms during herpes simplex virus entry.

Stiles KM, Krummenacher C.

Virology. 2010 Mar 30;399(1):109-19. doi: 10.1016/j.virol.2009.12.034. Epub 2010 Jan 20.

10.

Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.

Krieger SE, Zeisel MB, Davis C, Thumann C, Harris HJ, Schnober EK, Mee C, Soulier E, Royer C, Lambotin M, Grunert F, Dao Thi VL, Dreux M, Cosset FL, McKeating JA, Schuster C, Baumert TF.

Hepatology. 2010 Apr;51(4):1144-57. doi: 10.1002/hep.23445.

PMID:
20069648
11.

RNA interference and single particle tracking analysis of hepatitis C virus endocytosis.

Coller KE, Berger KL, Heaton NS, Cooper JD, Yoon R, Randall G.

PLoS Pathog. 2009 Dec;5(12):e1000702. doi: 10.1371/journal.ppat.1000702. Epub 2009 Dec 24.

12.

Cbl controls EGFR fate by regulating early endosome fusion.

Visser Smit GD, Place TL, Cole SL, Clausen KA, Vemuganti S, Zhang G, Koland JG, Lill NL.

Sci Signal. 2009 Dec 22;2(102):ra86. doi: 10.1126/scisignal.2000217.

13.

Endocytosis and recycling of tight junction proteins in inflammation.

Utech M, Mennigen R, Bruewer M.

J Biomed Biotechnol. 2010;2010:484987. doi: 10.1155/2010/484987. Review.

14.

Virus movements on the plasma membrane support infection and transmission between cells.

Burckhardt CJ, Greber UF.

PLoS Pathog. 2009 Nov;5(11):e1000621. doi: 10.1371/journal.ppat.1000621. Epub 2009 Nov 26. Review.

15.

Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants.

Catanese MT, Ansuini H, Graziani R, Huby T, Moreau M, Ball JK, Paonessa G, Rice CM, Cortese R, Vitelli A, Nicosia A.

J Virol. 2010 Jan;84(1):34-43. doi: 10.1128/JVI.02199-08.

16.

Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.

Schwarz AK, Grove J, Hu K, Mee CJ, Balfe P, McKeating JA.

J Virol. 2009 Dec;83(23):12407-14. doi: 10.1128/JVI.01552-09. Epub 2009 Sep 23.

17.

Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.

Park SY, Yoon SJ, Freire-de-Lima L, Kim JH, Hakomori SI.

Carbohydr Res. 2009 Aug 17;344(12):1479-86. doi: 10.1016/j.carres.2009.04.032. Epub 2009 May 13.

PMID:
19559406
18.

Intercellular junctional proteins as receptors and barriers to virus infection and spread.

Bergelson JM.

Cell Host Microbe. 2009 Jun 18;5(6):517-21. doi: 10.1016/j.chom.2009.05.009. Review.

19.

The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.

Benedicto I, Molina-Jiménez F, Bartosch B, Cosset FL, Lavillette D, Prieto J, Moreno-Otero R, Valenzuela-Fernández A, Aldabe R, López-Cabrera M, Majano PL.

J Virol. 2009 Aug;83(16):8012-20. doi: 10.1128/JVI.00038-09. Epub 2009 Jun 10.

20.

CD82 endocytosis and cholesterol-dependent reorganization of tetraspanin webs and lipid rafts.

Xu C, Zhang YH, Thangavel M, Richardson MM, Liu L, Zhou B, Zheng Y, Ostrom RS, Zhang XA.

FASEB J. 2009 Oct;23(10):3273-88. doi: 10.1096/fj.08-123414. Epub 2009 Jun 4.

Supplemental Content

Support Center